Neurotrials Research Inc Listed by sinobi Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups continue to target organizations holding sensitive research and health-related data, with listings on leak sites serving as a common pressure tactic in 2026. On May 08, 2026, Neurotrials Research Inc appeared on a site associated with the sinobi group, which stated that internal files had been taken during a ransomware incident.

The number of individuals affected remains unknown, and no further details on the volume or contents of any data have been made public. The incident highlights the exposure risks faced by clinical research facilities that store records on trial participants.

Inside the incident

Public information is limited to the May 08, 2026 listing. The group claims internal files were exfiltrated, but the timing of the intrusion, the method of access, and the scale of any encryption or data removal have not been disclosed by the organization or confirmed through independent reporting.

No statement from Neurotrials Research Inc regarding the incident or its response has been referenced in available records. The exact status of any demanded payment or data handling also remains undisclosed.

The group behind it: sinobi

Sinobi is a ransomware operator that maintains a leak site to list victims and, in some cases, publish samples of claimed data. Groups of this type typically rely on initial access through phishing, credential compromise, or unpatched systems, followed by data exfiltration and encryption to support extortion demands.

The listing of Neurotrials Research Inc constitutes the group’s claim of activity against this target. No independent verification of the claimed exfiltration or the group’s possession of specific files has been reported.

About Neurotrials Research Inc

Neurotrials Research Inc, founded in 1997, operates an outpatient and inpatient clinical research facility in Atlanta. The site includes a 12,000-square-foot space with a 15-bed sleep laboratory and inpatient unit used for conducting trials. The organization has completed more than 175 clinical trials involving over 2,500 volunteers in the Atlanta area.

Facilities of this kind collect and retain detailed records on study participants, including medical histories, consent forms, laboratory results, and protocol-specific data required for regulatory compliance and trial integrity.

What was likely exposed

The only data category named in connection with the listing is internal files exfiltrated during a ransomware attack. No inventory of file types, participant records, or other categories has been released.

Organizations conducting clinical trials routinely hold personal identifiers, health information, and research documentation on volunteers. The precise contents of any files taken in this case remain unconfirmed.

Why it matters

Exposure of research participant data can affect individual privacy, particularly where medical or identifying details are involved. For the organization, such incidents may lead to regulatory scrutiny, operational disruption, and costs associated with investigation and remediation.

Because the number of affected individuals and the nature of the files are not yet known, the full scope of potential consequences cannot be assessed from public information alone.

Were you affected?

Individuals who participated in trials at Neurotrials Research Inc or provided contact information to the facility should monitor their email and financial accounts for unusual activity. Enabling multi-factor authentication and reviewing privacy settings on associated services are standard initial steps.

Readers can run a free exposure scan of their email address against known breach data to check for appearances in previously published records.

AICompiled with AI assistance from public sources and published under our editorial standards.